Neumora Therapeutics Inc.’s stock tumbled 81% Thursday after the clinical-stage biotech said a late-stage trial of a treatment for major depressive disorder failed to meet its main goals.

Check out my comprehensive review of Pictory AI, and find out why it's one of the top AI video editors on the market.

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Copyright 2025 The Associated Press. All Rights Reserved. Traders work on the floor at the New York Stock Exchange in New York’s Financial District Thursday, Jan. 2 ...

Crude oil futures settle higher on the first trading day of the year amid some optimism about the outlook for the Chinese economy, while outsized U.S. product inventory builds looked bearish.

Shares of the Watertown-based company were down 80% as of midday Thursday after the news was announced. Another company from Lexington also disclosed a trial setback. Neumora Therapeutics Inc.

Neumora Therapeutics’ big bet on a new era of neuroscience has delivered an age-old result. The first of three late-stage readouts on Neumora’s lead drug candidate has ended in failure, wiping ...

News is a setback for the clinical-stage biotech and a drug that proved successful in earlier trials Neumora Therapeutics Inc.'s stock tumbled 81% Thursday after the clinical-stage biotech said a ...

The Bombay High Court on Thursday observed that it will no longer monitor the probe into the 2015 murder of Communist Party of India leader and rationalist writer Govind Pansare. The court ...

If you purchase an independently reviewed product or service through a link on our website, Rolling Stone may receive an affiliate commission. The 2025 Sugar Bowl has arrived, pitting SEC champion No.

San Francisco, California--(Newsfile Corp. - January 1, 2025) - On December 9, 2024, just months after conducting an initial public offering in September 2024, BioAge Labs, Inc. (NASDAQ: BIOA) made ...